HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jessica S Albert Selected Research

Rufous oculocutaneous albinism

10/2018Minimal Efficacy of Nitisinone Treatment in a Novel Mouse Model of Oculocutaneous Albinism, Type 3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jessica S Albert Research Topics

Disease

1Rufous oculocutaneous albinism
10/2018
1Oculocutaneous Albinism (Albinism, Yellow Mutant)
10/2018
1Nephrocalcinosis
03/2015
1Metabolic Bone Diseases (Osteopenia)
03/2015
1Cysts
03/2015
1Hypoglycemia (Reactive Hypoglycemia)
03/2015
1Respiratory Tract Infections (Respiratory Tract Infection)
03/2015
1Insulin Resistance
06/2014
1Inflammation (Inflammations)
06/2014
1Type 2 Diabetes Mellitus (MODY)
06/2014

Drug/Important Bio-Agent (IBA)

1Monophenol Monooxygenase (Tyrosinase)IBA
10/2018
1nitisinone (Orfadin)FDA Link
10/2018
1PolyaminesIBA
03/2015
1Retinaldehyde (Retinal)IBA
03/2015
1Proteins (Proteins, Gene)FDA Link
06/2014
1Sterol Esterase (Hormone-Sensitive Lipase)IBA
06/2014
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
06/2014
1Transcription Factors (Transcription Factor)IBA
06/2014